Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,333Revenue $M46,031Net Margin (%)1.7Z-Score1.3
Enterprise Value $M18,819EPS $0.8Operating Margin %7.8F-Score6
P/E(ttm))8.4Cash Flow Per Share $0Pre-tax Margin (%)2.6Higher ROA y-yN
Price/Book1.210-y EBITDA Growth Rate %0Quick Ratio0.8Cash flow > EarningsY
Price/Sales0.25-y EBITDA Growth Rate %0Current Ratio1.2Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %-3.5ROA % (ttm)1.6Higher Current Ratio y-yY
Dividend Yield %5.9Insider Buy (3m)0ROE % (ttm)10.3Less Shares Outstanding y-yN
Payout Ratio %55.0Shares Outstanding M399ROI % (ttm)0Gross Margin Increase y-yY

Gurus Latest Trades with BAK

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
BAKCharles Brandes 2010-09-30 Sold Out -0.02%$14.59 - $19.81
$ 8.74-48%Sold Out0
BAKCharles Brandes 2010-06-30 Reduce-0.01%$10.98 - $15.08
$ 8.74-35%Reduce -63.43%190,256
BAKCharles Brandes 2010-03-31 Reduce-0.01%$13.87 - $17.73
$ 8.74-42%Reduce -30.08%520,273
BAKCharles Brandes 2007-12-31 Add0.01%$16.14 - $19.7
$ 8.74-50%Add 24.25%1,434,785
BAKCharles Brandes 2007-09-30 Buy 0.04%$16.74 - $19.53
$ 8.74-52%New holding, 1154752 sh.1,154,752
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BAK is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

BAK: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about BAK :

    Quarterly/Annual Reports about BAK:

      News about BAK:

      Articles On GuruFocus.com
      The Best Dividends on May 1, 2012 Apr 30 2012 
      3 Promising Specialty Chemical Stocks Sep 12 2011 

      More From Other Websites
      02/12/2015 14:34 - Braskem posts net revenue or R$46 billion in 2014 Feb 12 2015
      Odebrecht Finance Ltd. -- Moody's changes the outlook on Construtora Norberto Odebrecht's Baa3... Jan 21 2015
      Mid-Day Market Update: Dow Edges Lower; Platinum Underwriters Shares Jump On Acquisition News Nov 24 2014
      Braskem (BAK) Is Weak On High Volume Today Nov 24 2014
      Braskem (BAK) Upgraded From Sell to Hold Nov 13 2014
      Rowan Companies Beats Q3 Earnings on Improved Dayrates Nov 10 2014
      McDermott International Incurs Wider-than-Expected Q3 Loss Nov 07 2014
      Is Braskem (BAK) a Great Growth Stock? Nov 07 2014
      QEP Resources Q3 Earnings Beat on High Production & Price Nov 06 2014
      Western Refining Earnings Beat in Q3 on Strong Core Biz Nov 06 2014
      3 Stocks Dragging The Chemicals Industry Downward Nov 06 2014
      11/06/2014 13:48 - BRASKEM POSTS NET REVENUE OF R$12 BILLION Nov 06 2014
      BRASKEM announces 3Q14 Results Nov 06 2014
      Pioneer Natural Beats on Q3 Earnings on Higher Production Nov 05 2014
      Weakness Seen in Tesco (TESO): Stock Tanks 14.4% Nov 05 2014
      Atwood (ATW) in Focus: Stock Falls 5.9% Nov 04 2014
      FuelCell Energy (FCEL) in Focus: Stock Rises 8.4% Nov 04 2014
      PetroChina Q3 Profit Falls on Poor Demand, Misses Estimate Nov 03 2014
      Weakness Seen in Midcoast Energy Partners (MEP): Stock Tanks 16.7% Nov 03 2014
      U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement Of Acquisition By Becton, Dickinson Oct 06 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial